SmartPill Wins 510(k) Release From FDA
Fri, 21 Jul 2006 06:00 AM EST
... SmartPill Corp., a leadingdeveloper of capsule-based medical devices based in Buffalo, N.Y., is proudto announce today that its SmartPill GI Monitoring System has received510(k) release from the federal Food and Drug Administration, granting thecompany a "green light" for the sale and use of its SmartPill GI MonitoringSystem and SmartPill pH.p Capsule in the United States. [click link for full article] ...
Related Topics
- Carbinoxamine and Pseudoephedrine Extended-Release Tablets
- Tacrolimus ointment
- Dietary Supplements
- Mammography
- Niacin Extended Release
- Lovastatin Extended Release
- Valproic Acid Delayed or Extended-Release or Sprinkle Capsule
- Carcinogens
- Pimecrolimus Cream 1%
- Metformin Extended-Release
- Dietary Guidelines
- Pseudoephedrine Extended Release
- Bupropion Extended-Release
- Chlorpromazine Extended-Release Capsules
- Amlodipine and Benazepril
- Thalidomide
- Quinidine Extended-Release
- Didanosine Delayed Release Capsule
- Isradipine Extended-Release Tablets
- Metronidazole Extended Release

Not Signed In -

